Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS
NCT04329637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74
Last updated 2020-04-01
Summary
Cyclic vomiting syndrome is a chronic functional gastrointestinal disorder that is a significant health care problem. It affects 1-2% of the population and imposes an enormous burden on patients, families and the health care system. Due to the recalcitrant nature of the disease, patients have high rates of health care utilization with multiple emergency department visits and hospitalizations. These in turn lead to school and work absenteeism, job loss, divorce and even disability. CVS is also associated with multiple comorbid conditions such as anxiety and depression, which further contribute to disease severity. Both neuroimaging studies and other data demonstrate the role of the central nervous system in the pathophysiology of CVS with stress being a significant trigger for episodes of CVS. In summary, CVS is common, disabling and expensive and is associated with significant psychosocial comorbidity that contributes to impaired quality of life . Our current healthcare delivery model is disease-centric and does not adequately address the psychosocial barriers that contribute to poor health in this patient population. We propose a novel, collaborative, integrative health care model that shifts the paradigm of care from one that is episodic and disease-centered to a patient-centered approach that addresses psychosocial determinants of health not addressed in our current traditional health care system. We will incorporate meditation practices that have been shown to reduce psychological distress and also add a care coordinator to our health care delivery team. The primary role of the care coordinator is to identify patient goals, preferences and barriers to self-management and address psychosocial and environmental issues that determine health. Patients will be randomized to either the integrative health care model or usual care. The primary aim of our study is to determine the impact of our proposed integrative health care model on health care outcomes which will include a reduction in psychological distress, improvement in coping skills for managing chronic disease, cognitive symptom management, improvement in health-related quality of life and reduction in health care utilization. This collaborative effort between physicians, community partners, and allied health personnel will redesign the health care delivery system, facilitate access to appropriate healthcare services, optimize chronic disease management and improve overall healthcare outcomes.
Conditions
- Cyclic Vomiting Syndrome
Interventions
- OTHER
-
Integrative healt care
Meditation and use of a care cordinator
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-05
- Primary Completion
- 2019-02-05
- Completion
- 2019-12-15
More Related Trials
-
Auricular Neurostimulation for Cyclic Vomiting Syndrome
NCT03434652 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics
NCT06390787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.
NCT04721171 ·Status: TERMINATED ·Phase: NA
-
Role of Vagal Tone in Rumination Syndrome
NCT03912636 ·Status: COMPLETED ·Phase: NA
-
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers
NCT02177890 ·Status: COMPLETED ·Phase: NA
-
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
NCT05004818 ·Status: COMPLETED ·Phase: NA
-
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
NCT06769165 ·Status: RECRUITING ·Phase: NA
-
Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis
NCT01165866 ·Status: COMPLETED ·Phase: PHASE4
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron
NCT02618343 ·Status: COMPLETED ·Phase: NA
-
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
NCT02143531 ·Status: COMPLETED ·Phase: PHASE4
-
Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis
NCT05065567 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration
NCT00691275 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021 ·Status: COMPLETED ·Phase: PHASE4
-
Developing Individualized Strategies to Prevent Nausea and Vomiting
NCT01393288 ·Status: WITHDRAWN ·Phase: NA
-
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
NCT03295760 ·Status: COMPLETED
-
Aromatherapy as Treatment for n/v of Pregnancy
NCT03609567 ·Status: COMPLETED ·Phase: NA
-
The Effect of Scent on Pregnancy Induced Nausea, Vomiting, and Quality of Life
NCT03513536 ·Status: COMPLETED ·Phase: NA
-
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
NCT00020657 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
NCT01625923 ·Status: TERMINATED ·Phase: NA
-
Visual Distraction as a Means of Enhancing Child Resistance
NCT01859780 ·Status: COMPLETED ·Phase: NA
-
The Effects of Ondansetron on Brain Function
NCT02460341 ·Status: COMPLETED ·Phase: PHASE1
-
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
NCT01510379 ·Status: COMPLETED ·Phase: NA
-
Domperidone for Chronic Nausea and Vomiting
NCT02757534 ·Status: NO_LONGER_AVAILABLE
-
Cereset Research For Chronic Nausea
NCT05229107 ·Status: WITHDRAWN ·Phase: NA